sox10 [Neurosurgery Wiki]

This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong.

Mechanistically, tumor cell differentiation is driven by selective white matter upregulation of [[SOX10]], a master regulator of normal [[oligodendrogenesis]]. [[SOX10]] overexpression or treatment with myelination-promoting agents that upregulate endogenous SOX10, mimic this response, leading to niche-independent pre-[[oligodendrocyte]] differentiation and [[tumor suppression]] in vivo. Thus, [[glioblastoma]] recapitulates an injury response, and exploiting this latent program may offer treatment opportunities for a subset of patients
((Brooks LJ, Clements MP, Burden JJ, Kocher D, Richards L, Devesa SC, Zakka L, Woodberry M, Ellis M, Jaunmuktane Z, Brandner S, Morrison G, Pollard SM, Dirks PB, Marguerat S, Parrinello S. The white matter is a pro-differentiative niche for glioblastoma. Nat Commun. 2021 Apr 12;12(1):2184. doi: 10.1038/s41467-021-22225-w. PMID: 33846316.)).